RECMGMT-L Archives

Records Management

RECMGMT-L@LISTSERV.IGGURU.US

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Chesley, Rikki" <[log in to unmask]>
Reply To:
Records Management Program <[log in to unmask]>
Date:
Mon, 7 May 2012 15:28:48 +0000
Content-Type:
text/plain
Parts/Attachments:
text/plain (110 lines)
Thank you all so much!

The short answer to all of your questions is, yes!  We are a research institution, so we work with many partners . . .

When this question was brought to me. . .  I took over the position here a hot 5 weeks ago . . . this was the first time in my RIM career that I think I want to keep it even longer than the business.  She wanted an extra five years and I thought it still didn't sound long enough, because Pharma scares me a bit to be honest . . . So thanks for your help.

Rikki

-----Original Message-----
From: Records Management Program [mailto:[log in to unmask]] On Behalf Of mwhaider
Sent: Monday, May 07, 2012 11:18 AM
To: [log in to unmask]
Subject: Re: Drug Trial Retention?

Hi Rikki,
Several questions come to my mind:
1.  Are the drug trial records a result of a research project at Emory University?
2.  If yes, do these records support the final project submission for approval?  If yes, then they probably need to be retained the same as the research project submission for approval; and possibly as long as the drug is on the market.
3.  If these records are in your custody for another entity then you need to consider what other regulations may apply to drug research records - not just the trials.  If they are for research/reference purposes you probably need the drug trial records as well as the approvals and all other records that provide the full story of the product.

In many cases, a research project is considered a record category, and all pertinent and relevant documents should be retained as a cohesive group.
So you may need to consider, "How long do we need to retain the information on this research project?  Is the product still on the market?  How long is the potential liability for the drug? " etc.

I'm not saying that every extraneous piece of information is required, but very careful that keep the whole story.  This applies to most research projects but I think drug research records carry a high level of risk so be careful before you shred.

Mary
Mary W. Haider, MBA, CRM
Records & Information Manager and Consultant [log in to unmask]
865-983-1371



On Mon, May 7, 2012 at 9:49 AM, Chesley, Rikki <[log in to unmask]>wrote:

> Hello list.
>
> I wonder if anyone out there is willing to help me?
>
> I have the FDA rules on drug trials, and I know this is going to shock
> and amaze you all, but  one of my researchers doesn't feel that this
> is quite long enough and is certain that there is an international
> standard out there that trumps and exceeds the FDA standards on the
> retention of drug trail information.  I have not found it.  I will be
> honest I only gave a modest effort knowing I could come to you and
> some of you must work in Pharma and know the regs inside and out.
>
> So, my question,  is there some ISO standard or standards governing
> retention of drug trial data and if so, will you please point me to it?
>
> Thanks and have a smashing Monday morning.
>
>
> Rikki Chesley, CRM
> University Records Manager
> Manuscript, Archives, and Rare Book Library Emory University Robert W.
> Woodruff Library
> 540 Asbury Circle
> Atlanta, Georgia 30322
> 404-727-8816
> [log in to unmask]
>
>
>
>
> ________________________________
>
> This e-mail message (including any attachments) is for the sole use of
> the intended recipient(s) and may contain confidential and privileged
> information. If the reader of this message is not the intended
> recipient, you are hereby notified that any dissemination,
> distribution or copying of this message (including any attachments) is
> strictly prohibited.
>
> If you have received this message in error, please contact the sender
> by reply e-mail message and destroy all copies of the original message
> (including attachments).
>
> List archives at http://lists.ufl.edu/archives/recmgmt-l.html
> Contact [log in to unmask] for assistance To unsubscribe
> from this list, click the below link. If not already present, place
> UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
> mailto:[log in to unmask]
>



--

List archives at http://lists.ufl.edu/archives/recmgmt-l.html
Contact [log in to unmask] for assistance To unsubscribe from this list, click the below link. If not already present, place UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
mailto:[log in to unmask]

________________________________

This e-mail message (including any attachments) is for the sole use of
the intended recipient(s) and may contain confidential and privileged
information. If the reader of this message is not the intended
recipient, you are hereby notified that any dissemination, distribution
or copying of this message (including any attachments) is strictly
prohibited.

If you have received this message in error, please contact
the sender by reply e-mail message and destroy all copies of the
original message (including attachments).

List archives at http://lists.ufl.edu/archives/recmgmt-l.html
Contact [log in to unmask] for assistance
To unsubscribe from this list, click the below link. If not already present, place UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
mailto:[log in to unmask]

ATOM RSS1 RSS2